Patents Assigned to Via Pharmaceuticals, Inc.
  • PHENYLALKYL N-HYDROXYUREAS FOR TREATING LEUKOTRIENE RELATED PATHOLOGIES
    Publication number: 20120029048
    Abstract: The method of treating patients by administering N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea for treatment of leukotriene related pathologies and compositions for this use.
    Type: Application
    Filed: February 10, 2011
    Publication date: February 2, 2012
    Applicant: VIA Pharmaceuticals, Inc.
    Inventors: Rebecca Taub, Tilmann Brotz, John Franc, Larry Cohen, Hemantkumar H. Patel, Sanjay R. Chemburkar, David P. Sawick
  • Diacylglycerol acyltransferase inhibitors
    Patent number: 8058299
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
    Type: Grant
    Filed: May 1, 2008
    Date of Patent: November 15, 2011
    Assignee: VIA Pharmaceuticals, Inc.
    Inventors: David Robert Bolin, Adrian Wai-Hing Cheung, Fariborz Firooznia, Matthew Michael Hamilton, Lee Apostle McDermott, Yimin Qian, Jenny Tan, Weiya Yun
  • Diacylglycerol acyltransferase inhibitors
    Patent number: 7714126
    Abstract: Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: May 11, 2010
    Assignee: Via Pharmaceuticals, Inc.
    Inventors: David Robert Bolin, Adrian Wai-Hing Cheung, Fariborz Firooznia, Matthew Michael Hamilton, Shiming Li, Lee Apostle McDermott, Yimin Qian, Weiya Yun
  • Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
    Patent number: 7495024
    Abstract: The method of treating patients be administering phenylalkyl N-hydroxurea derivatives for combating atherosclerotic plaque and cardiovascular diseases and compositions for this use.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: February 24, 2009
    Assignee: VIA Pharmaceuticals, Inc.
    Inventors: Raymond Tabibiazar, Melisa Cooper, Thomas Quertermous, Adeoye Olukotun
  • Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
    Patent number: 7410963
    Abstract: The invention relates to compounds having PDE2 inhibitory activities, as well as therapeutic methods by administering said compounds, in particular for treating various diseases of the central or peripheral nervous system. It further deals with pharmaceutical compositions comprising said compounds and methods for preparing said compounds.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: August 12, 2008
    Assignee: VIA Pharmaceuticals, Inc.
    Inventors: Mustapha Abarghaz, Stefano Biondi, Jérôme Duranton, Emmanuelle Limanton, Cesare Mondadori, Patrick Wagner
  • Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
    Patent number: 7250410
    Abstract: The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates.
    Type: Grant
    Filed: June 7, 2002
    Date of Patent: July 31, 2007
    Assignee: Via Pharmaceuticals, Inc.
    Inventors: Jean-Jacques Bourguignon, Yan Lagouge, Claire Lugnier, Eveline Klotz, Jean-Paul Macher, Pierre Raboisson, Dominique Schultz